Observational study / 2009
In a 10-patient case series, voluntary fasting alongside chemotherapy was feasible and linked to reported reductions in several chemotherapy side effects.
Ten patients diagnosed with various malignancies voluntarily fasted prior to (48-140 hours) and/or following (5-56 hours) an average of 4 cycles of chemotherapy. Patients reported no significant side effects from fasting other than hunger and lightheadedness. Six patients who underwent chemotherapy with and without fasting reported less fatigue, weakness, and gastrointestinal side effects during fasting cycles, while fasting did not prevent chemotherapy-induced reductions in tumor volume or tumor markers in evaluable patients. The authors caution that these 10 cases are not meant to establish practice guidelines.
Shows an association, not proof of cause and effect.
- Study type
- Case series
- Who was studied
- 10 cancer patients undergoing chemotherapy
- What was measured
- Feasibility, safety, fasting side effects, chemotherapy toxicity, and tumor response
THE PAPER
Fasting and cancer treatment in humans: A case series report.
Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD. Aging (Albany NY), 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.